Ursula Wiedermann

Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH₂ to TH₁ in T‐cell clones specific for Phi p 1, a major grass pollen allergen

C. Ebner, Ute Siemann, Barbara Bohle et al. · Clinical & Experimental Allergy · 1997 · 332 citations

Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling

Annika De Sousa Linhares, Claire Battin, Sabrina Jutz et al. · Scientific Reports · 2019 · 189 citations · Full text

Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial

Emil C. Reisinger, Roland Tschismarov, Eckhard Beubler et al. · The Lancet · 2018 · 176 citations

Vaccination, Vaccine Safety, Vaccinology +6

Bet v 1, the major birch pollen allergen, and Mal d 1, the major apple allergen, cross-react at the level of allergen-specific T helper cells

Ruth Fritsch‐Stork, Barbara Bohle, Ute Vollmann et al. · Journal of Allergy and Clinical Immunology · 1998 · 133 citations · Full text

Mucosal co-application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy

Andreas Repa, Corinne Grangette, Catherine Daniel et al. · Vaccine · 2003 · 127 citations

Environmental Allergy, Allergy, Allergy Medicine +8